Pesquisar um projeto de investigação
Outras opções de pesquisa
9 Resultado(s)
Projetos de investigação encerrados = 
Financiado por um membro do IRDiRC = 
Membro de uma ERN = 
Projetos de investigação
ALEMANHA
Berlin
ADDRESS: NOT PROVIDED - DE
JAKoMo: A Prospective, Two-arm, Non-interventional Study of JAKAVI® (Ruxolitinib) in Patients With Myelofibrosis
Institution: Information not provided - DE
ALEMANHA
Sachsen-Anhalt
HALLE (SAALE)
Pheno- and genotypes of JAK2 mutated patients with and without thromboembolic events. A project of the East German Study Group (OSHO)
Universitätsklinikum Halle (Saale)
Krukenberg-Krebszentrum Halle (KKH)
ALEMANHA
Sachsen-Anhalt
HALLE (SAALE)
MAry: Myeloproliferative Neoplasms - Young and Older Adults: Two Sides of the Same Coin? A multicentre non-interventional study of the East German Study Group for Haematology and Oncology (OSHO)
Universitätsklinikum Halle (Saale)
Krukenberg-Krebszentrum Halle (KKH)
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
Besremi-PASS: A Prospective, Multicentre, Non-interventional, Observational, Post-authorisation Safety Study of Ropeginterferon alfa-2b in Polycythaemia Vera Patients - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
Real-World Clinical and Patient Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib - AT
Institution: Information not provided - AT
CANADA
Ontario
TORONTO
Inherited bone marrow failure syndromes: from genomic discoveries to biology
Hospital for Sick Children, Research Institute
ESPANHA
Murcia
MURCIA
Identification of biomarkers of thrombotic risk in patients with myeloproliferative neoplasms: a clinical, biological and molecular approach
Hospital General Universitario Reina Sofía
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
FRANCA
NOUVELLE AQUITAINE
BORDEAUX
Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)
CHU de Bordeaux-GH Pellegrin
Service d'hématologie biologique
ITALIA
EMILIA ROMAGNA
MELDOLA